Russell Skibsted
Chief Financial Officer · 8 filings · Latest: Jul 26, 2026
Processa Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PCSA | Russell Skibsted | Chief Financial Officer | Jun 30, 2026 | Purchase | $1.93 | 3,277 | $6.3K | 16,689 | |
PCSA | Russell Skibsted | Chief Financial Officer | Jun 15, 2026 | Purchase | $2.22 | 2,654 | $5.9K | 13,412 | |
PCSA | Russell Skibsted | Chief Financial Officer | May 29, 2026 | Purchase | $2.57 | 2,292 | $5.9K | 10,758 | |
PCSA | Russell Skibsted | Chief Financial Officer | May 15, 2026 | Purchase | $2.97 | 1,984 | $5.9K | 8,466 | |
PCSA | Russell Skibsted | Chief Financial Officer | Apr 30, 2026 | Purchase | $2.69 | 2,190 | $5.9K | 6,498 | |
PCSA | Russell Skibsted | Chief Financial Officer | Apr 15, 2026 | Purchase | $2.97 | 1,984 | $5.9K | 4,308 | |
PCSA | Russell Skibsted | Chief Financial Officer | Mar 31, 2026 | Purchase | $2.54 | 2,324 | $5.9K | 2,324 |